Literature DB >> 25564400

The role of the ADAMTS13 cysteine-rich domain in VWF binding and proteolysis.

Rens de Groot1, David A Lane1, James T B Crawley1.   

Abstract

ADAMTS13 proteolytically regulates the platelet-tethering function of von Willebrand factor (VWF). ADAMTS13 function is dependent upon multiple exosites that specifically bind the unraveled VWF A2 domain and enable proteolysis. We carried out a comprehensive functional analysis of the ADAMTS13 cysteine-rich (Cys-rich) domain using engineered glycans, sequence swaps, and single point mutations in this domain. Mutagenesis of Cys-rich domain-charged residues had no major effect on ADAMTS13 function, and 5 out of 6 engineered glycans on the Cys-rich domain also had no effect on ADAMTS13 function. However, a glycan attached at position 476 appreciably reduced both VWF binding and proteolysis. Substitution of Cys-rich sequences for the corresponding regions in ADAMTS1 identified a hydrophobic pocket involving residues Gly471-Val474 as being of critical importance for both VWF binding and proteolysis. Substitution of hydrophobic VWF A2 domain residues to serine in a region (residues 1642-1659) previously postulated to interact with the Cys-rich domain revealed the functional importance of VWF residues Ile1642, Trp1644, Ile1649, Leu1650, and Ile1651. Furthermore, the functional deficit of the ADAMTS13 Cys-rich Gly471-Val474 variant was dependent on these same hydrophobic VWF residues, suggesting that these regions form complementary binding sites that directly interact to enhance the efficiency of the proteolytic reaction.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25564400      PMCID: PMC4366626          DOI: 10.1182/blood-2014-08-594556

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  34 in total

1.  The proximal carboxyl-terminal domains of ADAMTS13 determine substrate specificity and are all required for cleavage of von Willebrand factor.

Authors:  Jihui Ai; Paula Smith; Shuwei Wang; Ping Zhang; X Long Zheng
Journal:  J Biol Chem       Date:  2005-06-23       Impact factor: 5.157

2.  Shear-dependent changes in the three-dimensional structure of human von Willebrand factor.

Authors:  C A Siedlecki; B J Lestini; K K Kottke-Marchant; S J Eppell; D L Wilson; R E Marchant
Journal:  Blood       Date:  1996-10-15       Impact factor: 22.113

3.  The molecular basis for the chemical denaturation of proteins by urea.

Authors:  Brian J Bennion; Valerie Daggett
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-17       Impact factor: 11.205

4.  Binding of ADAMTS13 to von Willebrand factor.

Authors:  Elaine M Majerus; Patricia J Anderson; J Evan Sadler
Journal:  J Biol Chem       Date:  2005-04-11       Impact factor: 5.157

5.  Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.

Authors:  G G Levy; W C Nichols; E C Lian; T Foroud; J N McClintick; B M McGee; A Y Yang; D R Siemieniak; K R Stark; R Gruppo; R Sarode; S B Shurin; V Chandrasekaran; S P Stabler; H Sabio; E E Bouhassira; J D Upshaw; D Ginsburg; H M Tsai
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

6.  ADAMTS13 substrate recognition of von Willebrand factor A2 domain.

Authors:  Sara Zanardelli; James T B Crawley; Chan K N Chan Kwo Chion; Jonathan K Lam; Roger J S Preston; David A Lane
Journal:  J Biol Chem       Date:  2005-10-12       Impact factor: 5.157

7.  Characterization of a core binding site for ADAMTS-13 in the A2 domain of von Willebrand factor.

Authors:  Jing-Jiang Wu; Kazuo Fujikawa; Brad A McMullen; Dominic W Chung
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-22       Impact factor: 11.205

8.  Proteolytic inactivation of ADAMTS13 by thrombin and plasmin.

Authors:  James T B Crawley; Jonathan K Lam; James B Rance; Luigina R Mollica; James S O'Donnell; David A Lane
Journal:  Blood       Date:  2004-09-23       Impact factor: 22.113

9.  Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor.

Authors:  Xiaohui Zhang; Kenneth Halvorsen; Cheng-Zhong Zhang; Wesley P Wong; Timothy A Springer
Journal:  Science       Date:  2009-06-05       Impact factor: 47.728

10.  Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation.

Authors:  J L Moake; N A Turner; N A Stathopoulos; L H Nolasco; J D Hellums
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

View more
  16 in total

1.  ADAMTS13 and von Willebrand factor interactions.

Authors:  Catherine B Zander; Wenjing Cao; X Long Zheng
Journal:  Curr Opin Hematol       Date:  2015-09       Impact factor: 3.284

2.  ADAMTS13, lucky to have a hydrophobic pocket.

Authors:  X Long Zheng
Journal:  Blood       Date:  2015-03-19       Impact factor: 22.113

3.  Phylogenetic and functional analysis of ADAMTS13 identifies highly conserved domains essential for allosteric regulation.

Authors:  Joshua Muia; Jian Zhu; Suellen C Greco; Karen Vanhoorelbeke; Garima Gupta; Lisa A Westfield; J Evan Sadler
Journal:  Blood       Date:  2019-01-30       Impact factor: 22.113

4.  Antibodies that conformationally activate ADAMTS13 allosterically enhance metalloprotease domain function.

Authors:  An-Sofie Schelpe; Anastasis Petri; Elien Roose; Inge Pareyn; Hans Deckmyn; Simon F De Meyer; James T B Crawley; Karen Vanhoorelbeke
Journal:  Blood Adv       Date:  2020-03-24

5.  Massively parallel enzyme kinetics reveals the substrate recognition landscape of the metalloprotease ADAMTS13.

Authors:  Colin A Kretz; Manhong Dai; Onuralp Soylemez; Andrew Yee; Karl C Desch; David Siemieniak; Kärt Tomberg; Fyodor A Kondrashov; Fan Meng; David Ginsburg
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

6.  High throughput protease profiling comprehensively defines active site specificity for thrombin and ADAMTS13.

Authors:  Colin A Kretz; Kärt Tomberg; Alexander Van Esbroeck; Andrew Yee; David Ginsburg
Journal:  Sci Rep       Date:  2018-02-12       Impact factor: 4.379

7.  A model for the conformational activation of the structurally quiescent metalloprotease ADAMTS13 by von Willebrand factor.

Authors:  Kieron South; Marta O Freitas; David A Lane
Journal:  J Biol Chem       Date:  2017-02-16       Impact factor: 5.157

Review 8.  Monoclonal antibodies against metzincin targets.

Authors:  Salvatore Santamaria; Rens de Groot
Journal:  Br J Pharmacol       Date:  2018-04-02       Impact factor: 8.739

Review 9.  ADAM and ADAMTS Family Proteins and Snake Venom Metalloproteinases: A Structural Overview.

Authors:  Soichi Takeda
Journal:  Toxins (Basel)       Date:  2016-05-17       Impact factor: 4.546

10.  Conformational quiescence of ADAMTS-13 prevents proteolytic promiscuity.

Authors:  K South; M O Freitas; D A Lane
Journal:  J Thromb Haemost       Date:  2016-09-23       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.